Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging.
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac104
Abstract: OBJECTIVE To evaluate response rates at week 16 with ixekizumab in patients with radiographic axial spondyloarthritis (r-axSpA) and elevated or normal/low baseline inflammation, measured by serum C-reactive protein (CRP) or spinal MRI, using data from… read more here.
Keywords: sparcc mri; radiographic axial; axial spondyloarthritis; reactive protein ... See more keywords